Zou Yubao, Song Lei, Wang Zhimin, Ma Aiqun, Liu Tangwei, Gu Huimin, Lu Sailan, Wu Pengzhu, Zhang dagger Ying, Shen dagger Li, Cai Yuling, Zhen double dagger Yisong, Liu Yanling, Hui Rutai
Sino-German Laboratory for Molecular Medicine, Beijing, China.
Am J Med. 2004 Jan 1;116(1):14-8. doi: 10.1016/j.amjmed.2003.05.009.
To determine the prevalence of hypertrophic cardiomyopathy in China.
This epidemiologic investigation was performed in 8080 adults from nine communities across nine provinces in China from October 2001 to February 2002, using a multistage, random sample design. Hypertrophic cardiomyopathy was defined as nondilated ventricular hypertrophy, documented by echocardiography, that was not caused by any known cardiac or systemic disease.
Of the 4064 men and 4016 women who were screened, 13 (0.16%; 9 men and 4 women) had definite echocardiographic evidence for hypertrophic cardiomyopathy. The age- and sex-adjusted prevalence was about 80 per 100,000 adults.
Hypertrophic cardiomyopathy is not rare in China. Based on the estimated prevalence, there are at least 1 million cases in China.
确定中国肥厚型心肌病的患病率。
2001年10月至2002年2月，采用多阶段随机抽样设计，在中国九个省份的九个社区对8080名成年人进行了这项流行病学调查。肥厚型心肌病定义为经超声心动图证实的非扩张性心室肥厚，且不是由任何已知的心脏或全身性疾病引起的。
在接受筛查的4064名男性和4016名女性中，13人（0.16%；9名男性和4名女性）有明确的超声心动图证据表明患有肥厚型心肌病。经年龄和性别调整后的患病率约为每10万名成年人中有80例。
肥厚型心肌病在中国并不罕见。根据估计的患病率，中国至少有100万例病例。
